Achromobacter Spp: Description of Epidemiology and Resistance in Chronic Ear Infections and in Healthy Individuals. (AERIO)

University Hospital Center (CHU) Dijon Bourgogne

Status

Unknown

Conditions

Chronic Ear Infection

Epidemiology

Achromobacter

Treatments

Biological: Ear canal swab

Study type

Observational

Funder types

Other

Identifiers

NCT04483232

AMOUREUX FPA 2020

Details and patient eligibility

About

Hearing loss can be the result of chronic ear infections. The role of bacteria of the genus Achromobacter is not known in these conditions. An epidemiological study including a large number of patients is needed to compare the prevalence of these bacteria in sick and healthy subjects, and to highlight the characteristics of the strains and the factors favouring their emergence.

Enrollment

1,800 estimated patients

Sex

All

Ages

10+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Person or parent who has given his or her non-opposition
Person over 10 years of age
Sick Subjects Group :

diagnosis of chronic infection by an ENT specialist doctor if patient already included: new episode > 3 months after the complete clinical recovery from the previous episode observed by the ENT doctor - Healthy group: no ear infection in the last 6 months and no antibiotics in the previous month.

Exclusion criteria